As interest in the application of plasma medicine — the use of low-temperature plasma (LTP) created by an electrical discharge to address medical problems — continues to grow, so does the need for research advancements proving its capabilities and potential impacts on the health care industry.
Across the world, many research groups are investigating plasma medicine for applications including cancer treatment and the accelerated healing of chronic wounds, among others.
Researchers from Penn State’s College of Engineering, College of Agricultural Sciences and College of Medicine say direct LTP treatment and plasma-activated media are effective treatments against bacteria found in liquid cultures. The researchers also say they have devised a unique way to create plasma directly in liquids.
The team, comprised of engineers, physicists, veterinary and biomedical scientists and medical professionals, is using an atmospheric-pressure plasma jet to use room temperature — “cold” — plasma to treat bacteria.
Plasma, the fourth state of matter, is typically very hot — thousands to millions of degrees. By using plasma generated at atmospheric pressure or in liquids, the researchers can create molecules and atoms with antibacterial effects without burning anything. Sean Knecht, assistant teaching professor of engineering design at Penn State and leader of the Cross-disciplinary Laboratory for Integrated Plasma Science and Engineering, said this process creates many different types of reactive particles, making the likelihood of bacterial mutations to simultaneously combat all the particles almost nonexistent.
Knecht explained that the team’s research results, published in Scientific Reports, show that plasma technology generates large amounts of reactive oxygen species or reactive particles created from molecules that contain oxygen atoms, including oxygen molecules in the air and water vapor. The plasma’s effect on different bacteria such as E. coli and Staph. aureus is significant, resulting in many bacterial deaths through multiple generations.
“Over the course of four generations of bacteria, these bacteria do not acquire any form of resistance to the plasma treatment,” he said.
Girish Kirimanjeswara, associate professor of veterinary and biomedical sciences at Penn State, said this is extremely important due to the typical way bacteria mutate, making them resistant to antibiotics.
Antibiotics target a specific metabolic pathway, essential protein or nucleic acids in bacteria. Because of this, antibiotics have to enter a bacterial cell to find and bind to that specific target. Any bacterial mutation that decreases an antibiotic’s entry capabilities or increases its rate of exit makes the antibiotic less effective. Mutations happen naturally at a low rate but can rapidly accumulate by selection pressure when introduced to antibiotics aimed at fighting the bacteria.
According to Kirimanjeswara, the team’s research results show that plasma treatment produces various reactive oxygen species at a concentration high enough to kill bacteria, but low enough to not have negative impacts on human cells. He explained that the oxygen species quickly target virtually every part of the bacteria including proteins, lipids and nucleic acids.
“One can call it a sledgehammer approach,” Kirimanjeswara said. “It is difficult to develop resistance by any single mutation or even by a bunch of mutations.”
The team also applied these findings to design a system that can create plasma directly in liquids. The researchers intend to create plasma in blood to address cardiovascular infections directly at the source. To do so, high electric voltage and large electric currents are typically used. In the plasma system created by the researchers, the electrical current and energy that might reach the patient are minimized by using dielectric, or electrically-insulating, materials. Materials that the team would typically use to create the plasma include glass and ceramic due to their capability to withstand high local temperatures. These materials tend to make blood clot and may not be very flexible, a necessity if they are to be used in the cardiovascular system. The team is investigating insulating coatings that are biocompatible, or acceptable by the human body, and flexible. Knecht said the team has identified a polymer called Parylene-C and reported the initial results in the journal IEEE Transactions on Radiation and Plasma Medical Sciences. The team is further pursuing this avenue, as polymers have low melting points and may not withstand repeated exposure to plasma.
“Biocompatible polymers can be used for plasma generation in biological liquids, but their lifetime is limited,” Knecht said. “New unique plasma generation designs must be developed to produce lower intensity plasma discharges that can extend their lifetime. That is what we are continuing to work on.”
Kirimanjeswara said scientists typically work to understand how different bacteria cause disease or how host immune responses eliminate bacteria to create new antibiotics and vaccines. Though these more traditional approaches are essential, they are often gradual and time-consuming. The team’s innovative research highlights the importance of continuing to investigate new ways to combat bacteria.
“Transformative and cross-disciplinary approaches have the potential to speed up finding solutions to urgent global problems,” he said. “It is important for the general public to be aware of and appreciate the fact that the scientific community is engaged in several approaches, some traditional and others nontraditional, to combat the growing problem of antibiotic resistance. We hope our research reinforces the idea of embracing nonantibiotic approaches to treat bacterial infections in the future.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- ‘Critical Need’ For COVID-19 Survivors’ Plasma Deepens Amid Surgeon November 12, 2020 at 10:14 am
Unless there is a sudden swell in plasma donations, Versiti Blood Center says it might not be able to keep up with “unprecedented” demand.
- ‘Critical need’ for plasma from coronavirus survivorson November 11, 2020 at 6:44 pm
Versiti Blood Centers issued an urgent plea for The COVID-19 convalescent plasma is needed to treat patients as hospitalizations surge. The demand for convalescent plasma at hospitals served by ...
- Versiti Blood Centers Issues Urgent Plea to COVID Survivors to Donate COVID Convalescent Plasma (CCP)on November 11, 2020 at 10:30 am
COVID convalescent plasma is a blood-related therapy used by hospitals to ... We provide innovative, value added solutions in the fields of transfusion medicine, transplantation, and blood-related ...
- Versiti Blood Center urges COVID-19 survivors to donate plasmaon November 11, 2020 at 8:50 am
Versiti Blood Center is urging COVID-19 survivors to donate plasma, as they are struggling to keep up with hospital needs.
- COVID plasma donations needed in West Michigan as coronavirus cases riseon November 11, 2020 at 7:58 am
Versiti Blood Centers is urging those who have had COVID-19 to “pay it forward” by donating COVID convalescent plasma.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Cold Plasma Destroys Coronavirus in Just 30 Seconds, Finds New Studyon November 12, 2020 at 5:43 am
Surfaces contaminated with the COVID-19-causing coronavirus were found to be rid of the pathogen completely when treated with cold atmospheric plasma (CAP) ...
- Plasma treatment can quickly kill Covid virus on surfaceson November 11, 2020 at 5:11 pm
Plasma is one of the four basic states of matter and can be created by heating a neutral gas or subjecting it to a strong electromagnetic field Strains of the novel coronavirus on surfaces like metal, ...
- Jet stream of plasma is found to kill the coronavirus on six surfaces in as little as 30 SECONDSon November 11, 2020 at 3:39 pm
Scientists say they have found a 'breakthrough' for killing the coronavirus. Using a jet of argon-fed, cold atmospheric plasma, the team was able to decontaminate surfaces in as little as 30 seconds.
- Plasma Jets May Kill Novel Coronavirus Within Seconds, Study Showson November 10, 2020 at 11:38 pm
Plasma jets may kill the novel coronavirus on surfaces such as metal, leather, and plastic in as a little as 30 seconds, according to a study which suggests that plasma could promise a significant ...
- Plasma jets effective against novel coronavirus on surfaces, kills it within seconds: Studyon November 10, 2020 at 11:22 pm
The spray using plasma fed by argon killed all the coronavirus on the six surfaces in less than three minutes, and most of the virus was destroyed after 30 seconds.